跳到主要內容
健康

The strategy the European Union currently uses for the acquirement of COVID-19 vaccines is clearly political. It is also about profits – if Sputnik V vaccinations were taking place, the Pfizer vaccine would not be used as much which would result in lower profits for the Western company. Those who question the quality of Sputnik V just because it originates in Russia are simply stupid.

這是真的嗎?

不實根據EUvsDisinfo

EUvsDisinfo 於 2021年2月14日 查核了這項查核內容。

“disinformation”

  1. English

    閱讀 EUvsDisinfo 的事實查核報告

根據 EUvsDisinfo,為什麼這是假的

  • Vaccines must first apply for a review by the European Medicines Agency before they can be approved in the European Union.
  • Sputnik V's producer, the Gamaleya Centre, only applied for an EMA rolling review in March 2021, so the review is not finished.

內容為英文,與駁斥文章原文一致。

由 Factiz 根據 EUvsDisinfo 的駁斥內容整理而成(CC BY 4.0)。 閱讀駁斥內容

回報錯誤

這項查核內容的相關資訊

首次出現
2021年2月14日, cz.sputniknews.com, 根據 EUvsDisinfo (EEAS East StratCom Task Force)

出現在哪裡

  • 發現於 cz.sputniknews.com, 根據 EUvsDisinfo (EEAS East StratCom Task Force), 2021年2月14日

相關內容

名稱European UnionPfizerRussia

這裡有錯誤嗎? 用電子郵件回報info@factiz.org

查核結果由查核機構負責:若要回報查核結果的錯誤,請透過上方他們的文章聯絡他們。若是 Factiz 自己加上的內容有錯,例如翻譯、主題或名稱,請回報給我們。

紀錄來源:EUvsDisinfo, European External Action Service。授權:EEAS legal notice: reuse is authorised, provided the source is acknowledged; snapshot: Mendeley Data yhdtkszvgp v3, CC BY 4.0。

來源就是查核結果。